News

Thomas Willett (SYDE) and co-applicant Andrew Laing (Kinesiology) have been awarded $653,157 over four years from the Canadian Institutes for Health Research (CIHR) to study potential mechanisms of bone fragility originating in the organic phase of bone.

[WATERLOO COMPOSITE BIOMATERIAL SYSTEMS LAB]

Waterloo and Chile Meet

CBB members, Trevor Charles and Murray Moo-Young, hosted a workshop on biomanufacturing at UW, June 24-27, as part of a new IPRG collaborative project between UW and the Members of CeBiB at the University of

Dr. Gregory De Crescenzo from École Polytechnique de Montréal received a $1.65 million CREATE Grant. The proposal team consisted of experts from Polytechnique, McGill, University of Montreal, University of Quebec (INRS), and the University of Waterloo. From the University of Waterloo, CBB member's Marc Aucoin and Frank Gu were co-applicants on this proposal. 

Government of Canada announces more than $29 million in support for 18 research teams across the country

The CBB Received $1.6 million CREATE Grant from NSERC (CREATE - Competition Results - 2018)

$1.65 million will support launch of new biomedical technology graduate program.

NATHAN BRANIFF - JULY 13, 2018

This month we discuss synbio, regulation, and science advocacy with Professor Trevor Charles. Dr. Charles has been a professor in the department of biology at the University of Waterloo for 20 years and has been a strong advocate for synthetic biology research, both at Waterloo and in Canada.

People with diabetes could be able to monitor their blood sugar without drawing blood using a system now being developed at the University of Waterloo.

In a recent study, researchers combined radar and artificial intelligence (AI) technologies to detect changes in glucose levels without the need for painful finger pricks several times a day.

Waiting for the results of a biopsy can be an harrowing experience.

[UWaterloo Science News]

Professor Brian Dixon hosts Sajeev Kohli in his University of Waterloo lab, guiding him on experiments and helping to promote his work to the outside world.

Wong's Elucid Labs Non-Invasive Technology Promises to Reduce Biopsies  

A medical startup has developed cutting-edge imaging technology that has the potential to detect skin cancer without leaving a mark.

Elucid Labs uses artificial intelligence (AI) technology in a small non-invasive imaging device to analyze moles and other skin lesions for signs of skin cancer, helping dermatologists make faster, more accurate decisions and reducing the number of unnecessary biopsies.